Rapid Micro Biosystems Cash Flow Statement (2020-2026) | RPID

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-11.83M-24.99M-14.61M-14.93M-13.10M-16.34M-16.46M-13.89M-14.02M-13.39M-11.17M-13.32M-12.58M-11.32M-9.67M-11.26M-11.86M-11.51M-12.50M-14.28M
Share-based Compensation (Quarter)
1.22M
Gains from Sales and Divestitures (Quarter)
0.07M0.08M
Gains from Investment Securities (Quarter)
0.01M
Asset Writedowns and Impairment (Quarter)
0.01M0.02M0.05M0.17M0.11M0.03M0.09M0.01M-0.10M0.10M0.02M1.12M
Non-cash Items (Quarter)
1.89M66.23M31.04M2.10M2.43M
Cash from Operations (Quarter)
-15.06M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.00M-0.01M0.03M
Amortization of Deferred Charges (Quarter)
0.09M
Depreciation & Amortization (CF) (Quarter)
0.71M
Change in Working Capital
Change in Receivables (Quarter)
3.23M
Change in Inventory (Quarter)
-0.14M
Change in Account Payables (Quarter)
0.53M
Change in Accured Expenses (Quarter)
-2.23M
Other Working Capital Changes (Quarter)
0.32M
Investing Activities
Capital Expenditures (Quarter)
0.39M
Change in Acquisitions & Divestments (Quarter)
2.01M
Cash from Investing Activities (Quarter)
8.60M
Financing Activities
Other financing activities (Quarter)
1.53M
Cash from Financing Activities (Quarter)
0.25M
Additional items
Change in Cash (Quarter)
-6.21M
Free Cash Flow (Quarter)
-15.45M
Net Cash Flow (Quarter)
-6.21M